Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Editas Medicine stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EDIT.
You can purchase shares of Editas Medicine (NASDAQ:EDIT) through any online brokerage.
Other companies in Editas Medicine’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Quoin Pharmaceuticals (NASDAQ:QNRX), Larimar Therapeutics (NASDAQ:LRMR) and Fate Therapeutics (NASDAQ:FATE).
Editas Medicine has a consensus price target of $9.44.
The stock price for Editas Medicine (NASDAQ: EDIT) is $1.58 last updated April 24, 2025 at 1:02 PM EDT.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.